-
1
-
-
84860266865
-
International variation in prostate cancer incidence and mortality rates
-
Center MM, Jemal A, Lortet-Tieulent J et al. International variation in prostate cancer incidence and mortality rates. Eur. Urol. 2012; 61: 1079-92.
-
(2012)
Eur. Urol.
, vol.61
, pp. 1079-1092
-
-
Center, M.M.1
Jemal, A.2
Lortet-Tieulent, J.3
-
2
-
-
84856235306
-
Cruciferous vegetables intake and risk of prostate cancer: a meta-analysis
-
Liu B, Mao Q, Cao M, Xie L. Cruciferous vegetables intake and risk of prostate cancer: a meta-analysis. Int. J. Urol. 2012; 19: 134-41.
-
(2012)
Int. J. Urol.
, vol.19
, pp. 134-141
-
-
Liu, B.1
Mao, Q.2
Cao, M.3
Xie, L.4
-
3
-
-
0037464510
-
Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults
-
Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N. Engl. J. Med. 2003; 348: 1625-38.
-
(2003)
N. Engl. J. Med.
, vol.348
, pp. 1625-1638
-
-
Calle, E.E.1
Rodriguez, C.2
Walker-Thurmond, K.3
Thun, M.J.4
-
5
-
-
79955872008
-
Body mass index, prostate cancer-specific mortality, and biochemical recurrence: a systematic review and meta-analysis
-
Cao Y, Ma J. Body mass index, prostate cancer-specific mortality, and biochemical recurrence: a systematic review and meta-analysis. Cancer Prev. Res. 2011; 4: 486-501.
-
(2011)
Cancer Prev. Res.
, vol.4
, pp. 486-501
-
-
Cao, Y.1
Ma, J.2
-
6
-
-
33947202141
-
Obesity is associated with increased risks of prostate cancer metastasis and death after initial cancer diagnosis in middle-aged men
-
Gong Z, Agalliu I, Lin DW, Stanford JL, Kristal AR. Obesity is associated with increased risks of prostate cancer metastasis and death after initial cancer diagnosis in middle-aged men. Cancer 2007; 109: 1192-202.
-
(2007)
Cancer
, vol.109
, pp. 1192-1202
-
-
Gong, Z.1
Agalliu, I.2
Lin, D.W.3
Stanford, J.L.4
Kristal, A.R.5
-
7
-
-
0035313592
-
High-grade prostate cancer is associated with low serum testosterone levels
-
Schatzl G, Madersbacher S, Thurridl T et al. High-grade prostate cancer is associated with low serum testosterone levels. Prostate 2001; 47: 52-8.
-
(2001)
Prostate
, vol.47
, pp. 52-58
-
-
Schatzl, G.1
Madersbacher, S.2
Thurridl, T.3
-
8
-
-
0344406150
-
Pretreatment total testosterone level predicts pathological stage in patients with localized prostate cancer treated with radical prostatectomy
-
Massengill JC, Sun L, Moul JW et al. Pretreatment total testosterone level predicts pathological stage in patients with localized prostate cancer treated with radical prostatectomy. J. Urol. 2003; 169: 1670-5.
-
(2003)
J. Urol.
, vol.169
, pp. 1670-1675
-
-
Massengill, J.C.1
Sun, L.2
Moul, J.W.3
-
9
-
-
84876437430
-
Circulating free testosterone is an independent predictor of advanced disease in patients with clinically localized prostate cancer
-
Schnoeller T, Jentzmik F, Rinnab L et al. Circulating free testosterone is an independent predictor of advanced disease in patients with clinically localized prostate cancer. World J. Urol. 2013; 31: 253-9.
-
(2013)
World J. Urol.
, vol.31
, pp. 253-259
-
-
Schnoeller, T.1
Jentzmik, F.2
Rinnab, L.3
-
10
-
-
0033305020
-
A critical evaluation of simple methods for the estimation of free testosterone in serum
-
Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J. Clin. Endocrinol. Metab. 1999; 84: 3666-72.
-
(1999)
J. Clin. Endocrinol. Metab.
, vol.84
, pp. 3666-3672
-
-
Vermeulen, A.1
Verdonck, L.2
Kaufman, J.M.3
-
11
-
-
0034471041
-
Obesity: preventing and managing the global epidemic. Report of a WHO consultation
-
Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ. Tech. Rep. Ser. 2000; 894: 1-7.
-
(2000)
World Health Organ. Tech. Rep. Ser
, vol.894
, pp. 1-7
-
-
-
12
-
-
0030690915
-
Low serum testosterone and a younger age predict for a poor outcome in metastatic prostate cancer
-
Ribeiro M, Ruff P, Falkson G. Low serum testosterone and a younger age predict for a poor outcome in metastatic prostate cancer. Am. J. Clin. Oncol. 1997; 20: 605-8.
-
(1997)
Am. J. Clin. Oncol.
, vol.20
, pp. 605-608
-
-
Ribeiro, M.1
Ruff, P.2
Falkson, G.3
-
13
-
-
33748120911
-
Association between the dihydrotestosterone level in the prostate and prostate cancer aggressiveness using the Gleason score
-
Nishiyama T, Ikarashi T, Hashimoto Y, Suzuki K, Takahashi K. Association between the dihydrotestosterone level in the prostate and prostate cancer aggressiveness using the Gleason score. J. Urol. 2006; 176: 1387-91.
-
(2006)
J. Urol.
, vol.176
, pp. 1387-1391
-
-
Nishiyama, T.1
Ikarashi, T.2
Hashimoto, Y.3
Suzuki, K.4
Takahashi, K.5
-
14
-
-
35148851505
-
Prolonged exposure to reduced levels of androgen accelerates prostate cancer progression in Nkx3.1; Pten mutant mice
-
Banach-Petrosky W, Jessen WJ, Ouyang X et al. Prolonged exposure to reduced levels of androgen accelerates prostate cancer progression in Nkx3.1; Pten mutant mice. Cancer Res. 2007; 67: 9089-96.
-
(2007)
Cancer Res.
, vol.67
, pp. 9089-9096
-
-
Banach-Petrosky, W.1
Jessen, W.J.2
Ouyang, X.3
-
15
-
-
0037377311
-
Associations of serum testosterone with microvessel density, androgen receptor density and androgen receptor gene polymorphism in prostate cancer
-
Schatzl G, Madersbacher S, Haitel A et al. Associations of serum testosterone with microvessel density, androgen receptor density and androgen receptor gene polymorphism in prostate cancer. J. Urol. 2003; 169: 1312-15.
-
(2003)
J. Urol.
, vol.169
, pp. 1312-1315
-
-
Schatzl, G.1
Madersbacher, S.2
Haitel, A.3
-
16
-
-
0037812658
-
The influence of finasteride on the development of prostate cancer
-
Thompson IM, Goodman PJ, Tangen CM et al. The influence of finasteride on the development of prostate cancer. N. Engl. J. Med. 2003; 349: 215-24.
-
(2003)
N. Engl. J. Med.
, vol.349
, pp. 215-224
-
-
Thompson, I.M.1
Goodman, P.J.2
Tangen, C.M.3
-
17
-
-
84908021388
-
The Association between Finasteride use and High-grade or Lethal Prostate Cancer
-
Preston MA, Wilson K, Coseo-Markt S et al. The Association between Finasteride use and High-grade or Lethal Prostate Cancer. J. Urol. 2013; 189: e94 (Abstract 228).
-
(2013)
J. Urol
, vol.189
, pp. e94
-
-
Preston, M.A.1
Wilson, K.2
Coseo-Markt, S.3
-
18
-
-
84908031814
-
5 a reductase inhibitors and risk of prostate cancer. Nation-wide, population-based case-control study
-
Robinson D, Garmo H, Bill-Axelson A, Lorelei L, Holmberg L, Stattin P. 5 a reductase inhibitors and risk of prostate cancer. Nation-wide, population-based case-control study. J. Urol. 2013; 189: e795-6 (abstract 1941).
-
(2013)
J. Urol
, vol.189
, pp. e795-e796
-
-
Robinson, D.1
Garmo, H.2
Bill-Axelson, A.3
Lorelei, L.4
Holmberg, L.5
Stattin, P.6
-
19
-
-
84887609075
-
Obese men have more advanced and more aggressive prostate cancer at time of surgery than non-obese men after adjusting for screening PSA level and age: results from two independent nested case-control studies
-
Parker AS, Thiel DD, Bergstralh E et al. Obese men have more advanced and more aggressive prostate cancer at time of surgery than non-obese men after adjusting for screening PSA level and age: results from two independent nested case-control studies. Prostate Cancer Prostatic Dis. 2013; 20: 352-6.
-
(2013)
Prostate Cancer Prostatic Dis.
, vol.20
, pp. 352-356
-
-
Parker, A.S.1
Thiel, D.D.2
Bergstralh, E.3
-
20
-
-
62149129232
-
Is the body mass index a predictor of adverse outcome in prostate cancer after radical prostatectomy in a mid-European study population?
-
Pfitzenmaier J, Pritsch M, Haferkamp A et al. Is the body mass index a predictor of adverse outcome in prostate cancer after radical prostatectomy in a mid-European study population? BJU Int. 2009; 103: 877-82.
-
(2009)
BJU Int.
, vol.103
, pp. 877-882
-
-
Pfitzenmaier, J.1
Pritsch, M.2
Haferkamp, A.3
-
21
-
-
34547136177
-
Obesity does not predispose to more aggressive prostate cancer either at biopsy or radical prostatectomy in European men
-
Gallina A, Karakiewicz PI, Hutterer GC et al. Obesity does not predispose to more aggressive prostate cancer either at biopsy or radical prostatectomy in European men. Int. J. Cancer 2007; 121: 791-5.
-
(2007)
Int. J. Cancer
, vol.121
, pp. 791-795
-
-
Gallina, A.1
Karakiewicz, P.I.2
Hutterer, G.C.3
-
22
-
-
80053637321
-
Body mass index is not a predictor of biochemical recurrence after radical prostatectomy in Dutch men diagnosed with prostate cancer
-
Kok DE, van Roermund JG, Aben KK et al. Body mass index is not a predictor of biochemical recurrence after radical prostatectomy in Dutch men diagnosed with prostate cancer. World J. Urol. 2011; 29: 695-701.
-
(2011)
World J. Urol.
, vol.29
, pp. 695-701
-
-
Kok, D.E.1
van Roermund, J.G.2
Aben, K.K.3
-
23
-
-
84861234323
-
Obesity-related systemic factors promote an invasive phenotype in prostate cancer cells
-
Price RS, Cavazos DA, De Angel RE, Hursting SD, deGraffenried LA. Obesity-related systemic factors promote an invasive phenotype in prostate cancer cells. Prostate Cancer Prostatic Dis. 2012; 15: 135-43.
-
(2012)
Prostate Cancer Prostatic Dis.
, vol.15
, pp. 135-143
-
-
Price, R.S.1
Cavazos, D.A.2
De Angel, R.E.3
Hursting, S.D.4
deGraffenried, L.A.5
-
24
-
-
84876059411
-
Obesity and prostate cancer: weighing the evidence
-
Allott EH, Masko EM, Freedland SJ. Obesity and prostate cancer: weighing the evidence. Eur. Urol. 2013; 63: 800-9.
-
(2013)
Eur. Urol.
, vol.63
, pp. 800-809
-
-
Allott, E.H.1
Masko, E.M.2
Freedland, S.J.3
-
25
-
-
84876514140
-
New players for advanced prostate cancer and the rationalisation of insulin-sensitising medication
-
Gunter JH, Sarkar PL, Lubik AA, Nelson CC. New players for advanced prostate cancer and the rationalisation of insulin-sensitising medication. Int. J. Cell Biol. 2013; 2013: 834684.
-
(2013)
Int. J. Cell Biol.
, vol.2013
, pp. 834684
-
-
Gunter, J.H.1
Sarkar, P.L.2
Lubik, A.A.3
Nelson, C.C.4
-
26
-
-
36348982774
-
Obesity-related plasma hemodilution and PSA concentration among men with prostate cancer
-
Banez LL, Hamilton RJ, Partin AW et al. Obesity-related plasma hemodilution and PSA concentration among men with prostate cancer. JAMA 2007; 298: 2275-80.
-
(2007)
JAMA
, vol.298
, pp. 2275-2280
-
-
Banez, L.L.1
Hamilton, R.J.2
Partin, A.W.3
-
27
-
-
64549162443
-
Serum prostate-specific antigen hemodilution among obese men undergoing screening in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
-
Grubb RL III, Black A, Izmirlian G et al. Serum prostate-specific antigen hemodilution among obese men undergoing screening in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Cancer Epidemiol. Biomarkers Prev. 2009; 18: 748-51.
-
(2009)
Cancer Epidemiol. Biomarkers Prev.
, vol.18
, pp. 748-751
-
-
Grubb III, R.L.1
Black, A.2
Izmirlian, G.3
-
28
-
-
84880774348
-
Does obesity affect the accuracy of prostate-specific antigen (PSA) for predicting prostate cancer among men undergoing prostate biopsy
-
Oh JJ, Jeong SJ, Lee BK et al. Does obesity affect the accuracy of prostate-specific antigen (PSA) for predicting prostate cancer among men undergoing prostate biopsy. BJU Int. 2013; 112: E265-71. doi: 10.1111/j.464-410X.2012.11766.x
-
(2013)
BJU Int
, vol.112
, pp. E265-E271
-
-
Oh, J.J.1
Jeong, S.J.2
Lee, B.K.3
-
29
-
-
77957220643
-
A higher prediagnostic insulin level is a prospective risk factor for incident prostate cancer
-
Hammarsten J, Damber JE, Peeker R, Mellstrom D, Hogstedt B. A higher prediagnostic insulin level is a prospective risk factor for incident prostate cancer. Cancer Epidemiol. 2010; 34: 574-9.
-
(2010)
Cancer Epidemiol.
, vol.34
, pp. 574-579
-
-
Hammarsten, J.1
Damber, J.E.2
Peeker, R.3
Mellstrom, D.4
Hogstedt, B.5
|